The thymus is one of the primary immune organs in childhood. During embryonic development, the migration of the thymus from the cervical region to the mediastinum coincides with the formation of other structures in the anterior cervical region, which can result in anomalous thymic locations. Among these, the most frequent are cervical remnants of accessory thymic tissue along the normal migration path and thymic extensions that project beyond their usual location. Ectopic locations, which deviate from the normal embryological course, are less common. Radiologists must recognize these variants and their imaging manifestations to avoid misdiagnosis and incorrect interventions. This article aims to review and illustrate, using imaging, the embryology, normal development, anatomy, and the most common locations of thymic tissue outside its normal position in the anterior mediastinum in children.
Introduction Current evidence indicates that the outcomes obtained with the holmium laser (Ho:YAG) and the thulium fiber laser (TFL) in the endoscopic treatment of upper urinary tract stones are at least equivalent. The recent introduction of the pulsed thulium laser (p-Tm:YAG) could result, due to its characteristics, in the ideal combination of its predecessors. The aim of this study was to compare the performance and outcomes between high-power Ho:YAG and p-Tm:YAG. Material and methods This prospective randomized clinical study included patients with a single renal or ureteral stone, who underwent retrograde endoscopic surgery. Results A total of 122 patients were recruited, of whom 66 (54%) received treatment with the p-Tm:YAG laser. The overall stone-free rate was 65.1% for p-Tm:YAG and 62.5% for Ho:YAG (p = 0.76). Specifically, for renal stones, the stone-free rates were 60.9% vs 48.4% (p = 0.28), respectively. The median energy used in the p-Tm:YAG group was 4.71 kJ compared to 5.31 kJ in the Ho:YAG group (p = 0.28). The postoperative requirement for a double-J catheter was higher in the Ho:YAG group (67.8% vs 50%; p = 0.04). The analysis showed no statistically significant difference in the energy required to treat 1 mm3 of stone (20 J/mm3 for p-Tm:YAG vs 22 J/mm3 for Ho:YAG; p = 0.48). Conclusions Intracorporeal lithotripsy with p-Tm:YAG shows non-inferior results in terms of stone-free rates compared to high-power Ho:YAG. There is a trend in favor of p-Tm:YAG regarding the total energy required and a lower need for a subsequent double-J catheter, which should be corroborated by further studies in this field of urology.
PurposeThe integration of diagnostic tools, immunochemotherapy, targeted agents, and cellular therapies such as chimeric antigen receptor T-cell therapy (CAR-T) cells has transformed lymphoma outcomes in high-income countries. However, in Latin America (LATAM), access to these advances remains limited. This study aimed to assess lymphoma care access and institutional capacity in LATAM.MethodsWe conducted a cross-sectional digital survey from July 2025 to August 2025, coordinated by the Grupo de Estudio Latinoamericano de Linfoproliferativos network. The survey captured center-level data covering infrastructure, human resources, diagnostic and therapeutic availability, and clinical research activity. Data were analyzed using descriptive methods.ResultsA total of 73 hematology centers from 16 Latin American countries completed the survey. Most centers were public institutions (53%), with a median number of four hematologists per center (range, 2-10). While basic pathology and flow cytometry were widely available, access to advanced diagnostics was limited. Fifteen centers (21%) lacked immunohistochemistry, and pathology turnaround times exceeded 3 weeks in 56%. Positron emission tomography-computed tomography was available in 41% of centers. Novel therapies such as antibody-drug conjugates, bispecific antibodies, and checkpoint inhibitors were not available or restricted in most centers. Hematopoietic stem-cell transplantation was performed in 41% of centers, whereas commercial CAR-T was available in 5%. Clinical trials were conducted in 34% of centers.ConclusionOur findings highlight striking disparities between guideline-recommended lymphoma care and real-world institutional capacity across LATAM, underscoring the importance of collaborative efforts in building capacity and advocating for equitable access.
IntroductionUltrasound evaluation of thyroid nodules shows significant interobserver variability, contributing to the overutilization of fine-needle aspiration biopsy (FNA). Standardized systems such as TI-RADS aim to reduce this variability; however, their performance in real-world clinical practice remains heterogeneous. Artificial intelligence (AI) has emerged as a potential tool to support clinical decision-making in this setting.ObjectiveTo evaluate the clinical performance of an artificial intelligence model for recommending FNA in thyroid nodules and to compare it with ACR TI-RADS and Horvath TI-RADS classifications applied by specialists.Materials and methodsA retrospective cross-sectional study evaluating the clinical performance of an artificial intelligence model for FNA recommendation was conducted in adult patients who underwent thyroid ultrasound and FNA between January and December 2021. FNA recommendations generated by an AI model were compared with those issued by an expert radiologist and an expert endocrinologist using ACR TI-RADS and Horvath TI-RADS systems. The reference standard was cytology according to the Bethesda System, considering Bethesda ≥ III as a positive result, as an operational definition aligned with clinical decision-making for further diagnostic evaluation. Diagnostic performance metrics and concordance were calculated.ResultsA total of 101 patients were included (89.1% women), with a median age of 61 years and a median nodule size of 2.3 cm (IQR: 1.6–3.3). The AI model showed a sensitivity of 0.88 and a specificity of 0.41. Horvath TI-RADS, applied by an expert radiologist, demonstrated a sensitivity of 0.82 and a specificity of 0.69. Concordance between AI and TI-RADS–based methods were moderate.ConclusionIn a real-world clinical setting, the AI model demonstrated performance comparable to that of human specialists for recommending FNA in thyroid nodules. These findings support its potential role as a complementary decision-support tool, particularly in settings with variability in ultrasound interpretation.